These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26954520)

  • 1. Survival of smear-positive multidrug resistant tuberculosis patients in Witbank, South Africa: A retrospective cohort study.
    Olaleye AO; Beke AK
    Infect Dis (Lond); 2016; 48(6):422-7. PubMed ID: 26954520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013.
    Chingonzoh R; Manesen MR; Madlavu MJ; Sopiseka N; Nokwe M; Emwerem M; Musekiwa A; Kuonza LR
    PLoS One; 2018; 13(8):e0202469. PubMed ID: 30133504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Survival time and influencing factors in multidrug-resistant tuberculosis patients in Wuhan, 2006-2014].
    Wang JJ; Zhou ML; Chen C; Wu G; Zuo YP; Ren X; Chen Z; Wang WH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1409-1413. PubMed ID: 31838813
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
    Kliiman K; Altraja A
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.
    Atalell KA; Birhan Tebeje N; Ekubagewargies DT
    PLoS One; 2018; 13(5):e0197145. PubMed ID: 29787596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival model analysis of tuberculosis treatment among patients with human immunodeficiency virus coinfection.
    Azeez A; Mutambayi R; Odeyemi A; Ndege J
    Int J Mycobacteriol; 2019; 8(3):244-251. PubMed ID: 31512600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of mortality and loss to follow-up among drug resistant tuberculosis patients in Oromia Hospitals, Ethiopia: A retrospective follow-up study.
    Woldeyohannes D; Tekalegn Y; Sahiledengle B; Assefa T; Aman R; Hailemariam Z; Mwanri L; Girma A
    PLoS One; 2021; 16(5):e0250804. PubMed ID: 33956812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
    Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa.
    Heller T; Lessells RJ; Wallrauch CG; Bärnighausen T; Cooke GS; Mhlongo L; Master I; Newell ML
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):420-6. PubMed ID: 20202299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of mortality in a cohort of tuberculosis/HIV co-infected patients in Southwest Ethiopia.
    Gesesew H; Tsehayneh B; Massa D; Gebremedhin A; Kahsay H; Mwanri L
    Infect Dis Poverty; 2016 Dec; 5(1):109. PubMed ID: 27915999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.
    Assebe LF; Reda HL; Wubeneh AD; Lerebo WT; Lambert SM
    BMC Public Health; 2015 Apr; 15():346. PubMed ID: 25886730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of death among drug-resistant tuberculosis patients in Kuala Lumpur, Malaysia: A retrospective cohort study from 2009 to 2013.
    Mohd Shariff N; Shah SA; Kamaludin F
    J Glob Antimicrob Resist; 2016 Sep; 6():102-107. PubMed ID: 27530850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia.
    Alene KA; Viney K; McBryde ES; Tsegaye AT; Clements AC
    Trop Med Int Health; 2017 Mar; 22(3):351-362. PubMed ID: 27978594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistently high early mortality despite rapid diagnostics for drug-resistant tuberculosis cases in South Africa.
    Schnippel K; Firnhaber C; Ndjeka N; Conradie F; Page-Shipp L; Berhanu R; Sinanovic E
    Int J Tuberc Lung Dis; 2017 Oct; 21(10):1106-1111. PubMed ID: 28911353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associated factors with unsuccessful tuberculosis treatment outcomes among tuberculosis/HIV coinfected patients with drug-resistant tuberculosis.
    Azeez A; Ndege J; Mutambayi R
    Int J Mycobacteriol; 2018; 7(4):347-354. PubMed ID: 30531033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of sputum culture conversion time in multidrug-resistant tuberculosis patients in ALERT comprehensive specialized hospital, Addis Ababa, Ethiopia: A retrospective cohort study.
    Abebe M; Atnafu A; Tilahun M; Sero N; Neway S; Alemu M; Tesfaye G; Mihret A; Bobosha K; Wan C
    PLoS One; 2024; 19(5):e0304507. PubMed ID: 38820260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive-phase treatment outcomes among hospitalized multidrug-resistant tuberculosis patients: results from a nationwide cohort in Nigeria.
    Oladimeji O; Isaakidis P; Obasanya OJ; Eltayeb O; Khogali M; Van den Bergh R; Kumar AM; Hinderaker SG; Abdurrahman ST; Lawson L; Cuevas LE
    PLoS One; 2014; 9(4):e94393. PubMed ID: 24722139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achieving high treatment success for multidrug-resistant TB in Africa: initiation and scale-up of MDR TB care in Ethiopia--an observational cohort study.
    Meressa D; Hurtado RM; Andrews JR; Diro E; Abato K; Daniel T; Prasad P; Prasad R; Fekade B; Tedla Y; Yusuf H; Tadesse M; Tefera D; Ashenafi A; Desta G; Aderaye G; Olson K; Thim S; Goldfeld AE
    Thorax; 2015 Dec; 70(12):1181-8. PubMed ID: 26506854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa.
    Hirasen K; Berhanu R; Evans D; Rosen S; Sanne I; Long L
    PLoS One; 2018; 13(10):e0205463. PubMed ID: 30300403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.